Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns
about
Canadian practice guidelines for surgical intra-abdominal infectionsAntimicrobial resistance and susceptibility testing of anaerobic bacteriaIn vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.Antibiotic Susceptibility Pattern of Aerobic and Anaerobic Bacteria Isolated From Surgical Site Infection of Hospitalized Patients.In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections.Prophylactic efficacy of cephamycin plus fluoroquinolones in high risk patients on inhibiting infectious complications after transrectal prostate biopsy.Oral administration of live- or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1→3)-β-D-glucanSixteen homologs of the mex-type multidrug resistance efflux pump in Bacteroides fragilis.Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections.A review on metronidazole: an old warhorse in antimicrobial chemotherapy.
P2860
Q24599288-28E15AA2-5FD4-4E30-8A06-55E8F02AC798Q26829185-44D564C0-F028-4928-9187-896FDA326E96Q34301520-F2A8DFEB-60A6-4EB9-991C-B8B82319750AQ36095888-BD4DAA06-67E0-4E45-83CD-D8FBD8D12E2AQ40622123-2B4C6AD8-6A30-4006-B00D-530BFCBAFB49Q41099994-DC0E66D4-5A3F-4F31-8108-F24B42F085B8Q41152901-32044832-D4E0-464C-B9AE-461AD7DA8FE8Q42112690-8F66EE5F-83CA-4058-88C9-8FB1547F7441Q45074770-7C36489A-72C6-4D97-97E9-990D31D07EC2Q45816732-08BAD1EA-C4E2-467E-9CDE-4951A236B98EQ49790580-2AEF0741-4F8A-4059-B853-FD48ED9FE7DE
P2860
Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@ast
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@en
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@nl
type
label
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@ast
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@en
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@nl
prefLabel
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@ast
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@en
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@nl
P2093
P2860
P1476
Bacteremia due to Bacteroides ...... robial susceptibility patterns
@en
P2093
Charles V Sanders
Deborah Ashcraft
Kenneth E Aldridge
Megan O'Brien
P2860
P304
P356
10.1128/AAC.47.1.148-153.2003
P407
P577
2003-01-01T00:00:00Z